logo
#

Latest news with #JoeKiani

Masimo finds buyer for consumer audio business
Masimo finds buyer for consumer audio business

Yahoo

time08-05-2025

  • Business
  • Yahoo

Masimo finds buyer for consumer audio business

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Masimo said Tuesday it agreed to sell its Sound United consumer audio portfolio for $350 million to Samsung Electronics' Harman International unit, freeing the company to focus on its professional healthcare business. The sale is expected to close by the end of 2025, subject to regulatory approvals. The $1 billion acquisition of Sound United in 2022 was at the center of a proxy fight that ultimately led to the resignation of Masimo founder and longtime CEO Joe Kiani. Masimo lowered its 2025 earnings per share forecast due to the impact of tariffs but maintained its revenue outlook in its first-quarter earnings release. The patient monitoring company also disclosed a cybersecurity incident that is limiting its ability to fulfill orders. The sale price for Sound United, whose brands include Bowers & Wilkins, Denon and Marantz, is at a steep discount to what Masimo paid for the business three years ago. When Masimo bought Sound United, Kiani championed the acquisition as an opportunity to leverage the company's consumer expertise, but investors questioned the strategy. Activist shareholder Politan Capital Management, arguing the deal and subsequent selloff in Masimo's shares were the result of poor management, won a majority of seats on the company's board after a two-year battle. Kiani left the company soon after. In finding a buyer for Sound United, the new Masimo board has achieved one of its main objectives, said Vice Chairman Quentin Koffey. BTIG analyst Marie Thibault, in a note to investors Tuesday, called the Sound United sale a positive for the company and noted that Masimo would have increased its profit forecast if not for the impact of tariffs. Thibault believes the company's counteractions will likely be enough to achieve its financial guidance. Masimo expects tariff impacts would reduce its 2025 non-GAAP earnings per share by 45 cents to 50 cents, before any tariff mitigation, to a range of $4.80 to $5.15. The company said it has developed mitigation plans that it will reassess and modify as needed, including adjusting product sourcing and operations. The cyberattack on some of its manufacturing facilities, which Masimo discovered on April 27 and disclosed in a securities filing, disrupted the company's website and several computer systems but is not expected to affect its financial guidance. Recommended Reading Masimo, amid leadership transition, targets cost reductions

The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote
The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote

Yahoo

time05-05-2025

  • Business
  • Yahoo

The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote

DANA POINT, Calif., May 05, 2025--(BUSINESS WIRE)--The Lens, LSI's executive-focused medtech magazine, proudly unveils Volume 2, Edition 3, featuring Joe Kiani, Founder and Executive Chairman of Willow Laboratories and visionary of the digital-health platform Nutu, as its cover story.​ Kiani, a trailblazing figure in health technology, shares exclusive insights into the future of patient monitoring, the evolution of medical device innovation and the critical role of patient safety initiatives globally. In the powerful discussion, Joe Kiani and the Audacity to Care: Reflections on Principle, Persistence, and Patient-Centered Innovation, Kiani shares the journey that began in a garage with a $40,000 loan and now shapes standards of care for hundreds of millions of patients worldwide. The profile charts his early pulse-oximetry breakthroughs at Masimo, his bold crusades against entrenched purchasing monopolies, and his latest mission to out-innovate diabetes through Willow Labs.​ He also opens up about founding the Patient Safety Movement Foundation and leading the charge toward eliminating preventable deaths in hospitals worldwide. "We have a real responsibility and an opportunity to change people's lives for the better," said Kiani. "And it's not easy. But it's everything." The in-depth feature also spotlights Nutu, Willow Labs' science-backed "nudge" platform that empowers people with pre-diabetes to reverse disease progression through personalized, data-driven coaching.​ Kiani also shares his vision for the future, where technology and compassion merge to save lives. "Sometimes the unintended consequences of what we do are greater than the consequences we planned. But if you keep your compass set on doing what's right for patients, good things can happen," Kiani adds. "Joe Kiani embodies the spirit of innovation and impact that The Lens seeks to celebrate," said Scott Pantel, CEO of LSI. "His unwavering commitment to advancing healthcare outcomes makes him one of the most influential voices in our industry today." The latest issue of The Lens is available for subscribers in print and digitally. To become a subscriber and access the full cover story, visit Marquee Keynote at LSI USA '25 Building on the cover collaboration, LSI was honored to host Joe Kiani to deliver the opening keynote address at LSI USA '25, March 17-21, 2025, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California.​ Kiani's appearance opened a week that drew more than 1,600 executives, 450 emerging startup companies, 350 active investors from venture capital, private equity, family offices, accelerators, and angel groups, and key decision makers from multinational corporations including Medtronic, Boston Scientific, Intuitive and more. Kiani's remarks underscored the summit's 2025 theme of preventive and personalized care. "Landing Joe was mission-critical for our 2025 program," said Scott Pantel, CEO of LSI and Publisher of The Lens. "His career embodies the audacity and patient-first ethos we work to amplify. From Masimo's garage-born breakthroughs to Willow's prevention-focused playbook, Joe speaks to the heart of why this community convenes with us each spring." About The Lens Magazine Built by medtech insiders, for medtech executives, The Lens magazine is LSI's most refined industry coverage. Each monthly edition of The Lens features data-driven industry insights, in-depth executive profiles, and exclusive market analyses for global medtech leaders. Individual and team-wide subscriptions can be started at About LSI USA With a vision to create a new platform for connection and exposure — one that matched the pace, ambition, and quality of the executives driving medtech forward — LSI launched its first Emerging Medtech Summit in Dana Point, California in 2020. To date, LSI has hosted nine summits and welcomed more than 10,000 global executives from 54 countries. Attendees of LSI USA include C-Suite executives, strategic acquirers, capital providers, and policy leaders, from companies including 3M, Abbott, Allergan, Boston Scientific, Cardinal Health, Cleveland Clinic, Danaher, Deloitte, Edwards Lifesciences, GE Healthcare, Goldman Sachs, Hologic, Integra Lifesciences, Intuitive Surgical, Johnson & Johnson, JP Morgan, Mayo Clinic, Medtronic, Olympus, Siemens Healthineers, Smith & Nephew, Stryker, Terumo, Varian, and Zimmer Biomet. On March 16 – 20th 2026, LSI USA will return to the Waldorf Astoria Monarch Beach Resort in Dana Point, California. The Summit will feature four days of curated 1:1 meetings, panel and keynote talks, emerging company pitches and technology showcases. Register today at View source version on Contacts Media Contact Henry Peck, Chief Business Officerinfo@ 714-847-3540 Sign in to access your portfolio

The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote
The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote

Business Wire

time05-05-2025

  • Business
  • Business Wire

The Lens Magazine Features Joe Kiani, Willow Laboratories Founder and Nutu Visionary, on Cover of Latest Issue Following LSI USA ‘25 Keynote

DANA POINT, Calif.--(BUSINESS WIRE)-- The Lens, LSI's executive-focused medtech magazine, proudly unveils Volume 2, Edition 3, featuring Joe Kiani, Founder and Executive Chairman of Willow Laboratories and visionary of the digital-health platform Nutu, as its cover story.​ Kiani, a trailblazing figure in health technology, shares exclusive insights into the future of patient monitoring, the evolution of medical device innovation and the critical role of patient safety initiatives globally. In the powerful discussion, Joe Kiani and the Audacity to Care: Reflections on Principle, Persistence, and Patient-Centered Innovation, Kiani shares the journey that began in a garage with a $40,000 loan and now shapes standards of care for hundreds of millions of patients worldwide. The profile charts his early pulse-oximetry breakthroughs at Masimo, his bold crusades against entrenched purchasing monopolies, and his latest mission to out-innovate diabetes through Willow Labs.​ He also opens up about founding the Patient Safety Movement Foundation and leading the charge toward eliminating preventable deaths in hospitals worldwide. 'We have a real responsibility and an opportunity to change people's lives for the better,' said Kiani. 'And it's not easy. But it's everything.' The in-depth feature also spotlights Nutu, Willow Labs' science-backed 'nudge' platform that empowers people with pre-diabetes to reverse disease progression through personalized, data-driven coaching.​ Kiani also shares his vision for the future, where technology and compassion merge to save lives. 'Sometimes the unintended consequences of what we do are greater than the consequences we planned. But if you keep your compass set on doing what's right for patients, good things can happen,' Kiani adds. "Joe Kiani embodies the spirit of innovation and impact that The Lens seeks to celebrate," said Scott Pantel, CEO of LSI. "His unwavering commitment to advancing healthcare outcomes makes him one of the most influential voices in our industry today." The latest issue of The Lens is available for subscribers in print and digitally. To become a subscriber and access the full cover story, visit Marquee Keynote at LSI USA '25 Building on the cover collaboration, LSI was honored to host Joe Kiani to deliver the opening keynote address at LSI USA '25, March 17-21, 2025, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California.​ Kiani's appearance opened a week that drew more than 1,600 executives, 450 emerging startup companies, 350 active investors from venture capital, private equity, family offices, accelerators, and angel groups, and key decision makers from multinational corporations including Medtronic, Boston Scientific, Intuitive and more. Kiani's remarks underscored the summit's 2025 theme of preventive and personalized care. 'Landing Joe was mission-critical for our 2025 program,' said Scott Pantel, CEO of LSI and Publisher of The Lens. 'His career embodies the audacity and patient-first ethos we work to amplify. From Masimo's garage-born breakthroughs to Willow's prevention-focused playbook, Joe speaks to the heart of why this community convenes with us each spring.' About The Lens Magazine Built by medtech insiders, for medtech executives, The Lens magazine is LSI's most refined industry coverage. Each monthly edition of The Lens features data-driven industry insights, in-depth executive profiles, and exclusive market analyses for global medtech leaders. Individual and team-wide subscriptions can be started at About LSI USA With a vision to create a new platform for connection and exposure — one that matched the pace, ambition, and quality of the executives driving medtech forward — LSI launched its first Emerging Medtech Summit in Dana Point, California in 2020. To date, LSI has hosted nine summits and welcomed more than 10,000 global executives from 54 countries. Attendees of LSI USA include C-Suite executives, strategic acquirers, capital providers, and policy leaders, from companies including 3M, Abbott, Allergan, Boston Scientific, Cardinal Health, Cleveland Clinic, Danaher, Deloitte, Edwards Lifesciences, GE Healthcare, Goldman Sachs, Hologic, Integra Lifesciences, Intuitive Surgical, Johnson & Johnson, JP Morgan, Mayo Clinic, Medtronic, Olympus, Siemens Healthineers, Smith & Nephew, Stryker, Terumo, Varian, and Zimmer Biomet. On March 16 – 20 th 2026, LSI USA will return to the Waldorf Astoria Monarch Beach Resort in Dana Point, California. The Summit will feature four days of curated 1:1 meetings, panel and keynote talks, emerging company pitches and technology showcases. Register today at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store